Hermann Laferl
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Human recombinant soluble ACE2 in severe COVID-19(2020)422 cited
- → Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response(2008)252 cited
- → Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment(2016)221 cited
- → Epidemiology and Clinical Features of Imported Dengue Fever in Europe: Sentinel Surveillance Data from TropNetEurop(2002)171 cited
- → Acute Encephalopathy Associated with Influenza A Virus Infection(2003)120 cited
- → Age as a Risk Factor for Severe Manifestations and Fatal Outcome of Falciparum Malaria in European Patients: Observations from TropNetEurop and SIMPID Surveillance Data(2003)118 cited
- → Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response(2009)118 cited
- → Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection(2011)96 cited
- → Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop.(2004)90 cited
- → Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfection(2006)73 cited